Products

VUNO Med-Chest X-ray Triage/VUNO Med-CXR Link Triage
VUNO Inc.
Radiology & Imaging AI
VUNO Med-Chest X-ray Triage/VUNO Med-CXR Link Triage is an FDA-cleared AI-based software that analyzes adult chest X-rays to rapidly detect pleural effusion and pneumothorax, prioritizing urgent cases in clinical workflows.
VUNO Med-DeepBrain
VUNO
Neurology AI
VUNO Med-DeepBrain is an FDA-cleared AI-powered software that performs quantitative analysis of brain MRI scans, providing volumetric data and other metrics to aid in the early diagnosis of Alzheimer's and other neurodegenerative diseases.

See all 2 products →

About VUNO

VUNO is a leading South Korean medical AI company that develops and commercializes deep learning-based medical AI solutions. The company’s core mission is to leverage AI technology to enhance healthcare by enabling early disease detection and prevention, ultimately aiming to improve the quality of life for patients. VUNO’s solutions analyze a wide range of medical data, including bio-signals (ECG, respiratory rate, blood pressure, temperature), medical images (X-rays, CT scans, fundus images, brain MRI), and digital pathology data.

For physicians, VUNO’s products are designed to streamline workflows, aid in accurate diagnoses, and predict critical events. For example, VUNO Med-DeepCARS is an AI-powered solution that monitors vital signs to predict in-hospital cardiac arrest within 24 hours, providing crucial data for rapid response teams. Other offerings include AI-based medical image analysis software like VUNO Med-BoneAge for bone age assessment, VUNO Med-Chest X-ray for detecting pulmonary diseases, VUNO Med-Fundus AI for ophthalmology, and VUNO Med-DeepBrain for quantifying brain volume in neurodegenerative diseases. The company also has AI solution pipelines in digital pathology for various cancers, including stomach and prostate, focusing on morphometric measurement, diagnostic assistance, and treatment response prediction. VUNO emphasizes that its AI tools are intended to be supplemental, assisting physicians in making quicker and more accurate diagnoses and improving the efficiency and consistency of data analysis.

Focus Areas

Medical imaging diagnostics biosignal analysis medical speech recognition early disease detection neurodegenerative diseases cardiac arrest prediction lung diseases eye conditions bone age analysis preventive healthcare health management

Business Intelligence

TechnologyDeep learning-based AI solutions, AI-driven medical solutions, analyzes medical imaging (2D & 3D), biosignals (vital signs, ECG), and medical speech recognition

What Physicians Need to Know

Medical Imaging Diagnostics
VUNO offers AI-powered solutions for analyzing various medical images, including X-rays, CT scans, and MRIs. Their products include VUNO Med®-Chest X-ray™ for detecting lung diseases, VUNO Med®-DeepBrain™ for quantitative analysis of brain atrophy and white matter hyperintensity to aid in diagnosing neurodegenerative diseases like Alzheimer's, and VUNO Med®-LungCT AI for pulmonary nodule detection.
Biosignal Analysis & Early Disease Detection
VUNO Med®-DeepCARS® is a key AI-based solution that predicts cardiac arrest within 24 hours by analyzing four vital signs (blood pressure, heart rate, respiratory rate, and temperature). This tool helps medical professionals identify high-risk patients and manage care more effectively.
Neurodegenerative Diseases
VUNO Med®-DeepBrain™ assists in the diagnosis of neurodegenerative disorders by parcellating the brain into over 100 parts using 3D T1 non-contrast MRI and providing quantitative data on volume, normative percentiles, and cortical thickness. It helps detect cerebral small vessel disease and quantify brain atrophy.
Lung Diseases
VUNO Med®-Chest X-ray™ is a deep learning-based screening solution for five major lung diseases: Nodule/Mass, Consolidation, Interstitial Opacity, Pneumothorax, and Pleural Effusion. VUNO Med®-LungCT AI also provides robust detection of pulmonary nodules in chest CT scans.
Eye Conditions
VUNO Med-Fundus AI is an AI-powered solution for analyzing fundus images.
Bone Age Analysis
VUNO Med-BoneAge provides accurate bone age assessment by suggesting the three nearest matching bone age results within seconds, aiding pediatric radiologists and pediatricians in diagnosing skeletal maturity.
Preventive Healthcare & Health Management
VUNO's overarching mission is to leverage AI for early disease detection and prevention, aiming to improve patient outcomes, reduce costs, and enhance the efficiency of healthcare staff. Their solutions contribute to a more proactive approach to health management.
Physician Tip

VUNO's AI solutions are designed to act as an 'instant neuroradiologist co-pilot' and diagnostic support tools, providing rapid and consistent data analysis. For general practitioners and non-specialists, tools like VUNO Med-BoneAge can be a significant aid, while VUNO Med-DeepCARS helps manage all patients effectively by identifying those at higher risk of severe conditions, thereby lightening the workload and enhancing efficiency. The integration of VUNO's AI with mobile X-ray systems allows for instant AI results at the patient's bedside, which is critical in emergency rooms and intensive care units.

VUNO's solutions are designed for seamless integration with existing clinical workflows and systems like PACS (Picture Archiving and Communication Systems). They have also partnered with companies like Samsung Electronics to embed their AI algorithms directly into medical equipment, such as mobile digital X-ray systems, enabling on-the-spot AI analysis. VUNO processes patient data on behalf of hospitals, using pseudonymized data for AI development, and holds ISO/IEC 27001 and ISO/IEC 27701 certifications.

Products by VUNO

2 products in the directory

VUNO Med-Chest X-ray Triage/VUNO Med-CXR Link Triage
VUNO Inc.
Radiology & Imaging AI
VUNO Med-Chest X-ray Triage/VUNO Med-CXR Link Triage is an FDA-cleared AI-based software that analyzes adult chest X-rays to rapidly detect pleural effusion and pneumothorax, prioritizing urgent cases in clinical workflows.
VUNO Med-DeepBrain
VUNO
Neurology AI
VUNO Med-DeepBrain is an FDA-cleared AI-powered software that performs quantitative analysis of brain MRI scans, providing volumetric data and other metrics to aid in the early diagnosis of Alzheimer's and other neurodegenerative diseases.

What the Web Says

VUNO is a South Korean medical AI company specializing in AI-powered diagnostic support solutions for various medical fields, including cardiology, neurology, and ophthalmology. They have achieved significant milestones, including multiple breakthrough device designations in South Korea and FDA clearance in the US for some of their products. Ventuno Technologies, a separate entity, focuses on providing a comprehensive platform for managing, distributing, and monetizing video content for broadcasters and OTT service providers.

Overall: Mixed

Strengths

  • VUNO's AI solutions improve diagnostic accuracy and efficiency for medical professionals.
  • VUNO's products, like VUNO Med-DeepCARS, help identify high-risk patients and lighten healthcare staff workload.
  • VUNO has received positive feedback for its AI solutions and government support in the healthcare industry.
  • Ventuno Technologies is described as inexpensive and problem-solving oriented for CTV and mobile VOD apps.
  • Ventuno Technologies offers a ready-to-help customer care team, available almost 24 hours.
  • Ventuno Technologies is easy to use and user-friendly, with all options available for OTT platform development.

Limitations

  • Ventuno Technologies takes a long time to refresh CMS playlists.
  • Ventuno Technologies' payment options need improvement for easier payment.
  • There are not enough reviews for Ventuno Technologies on G2 to provide comprehensive buying insight.
  • Some similarly named companies (e.g., Veyluno, VionB) have been associated with scams or low-quality products.
  • Uno Health, another similarly named company, has very negative employee reviews regarding management, job security, and work-life balance.

Based on reviews from: G2, BioWorld, PitchBook, The Worldfolio, VUNO Official Website, KBR, Trustpilot, Capterra, Reddit, Indeed.com

Last updated: 2026-07-20

Videos

News, demos, and interviews about VUNO.

Loading videos...

Videos load interactively. If none appear, search YouTube for VUNO →

View all on YouTube

Press & Coverage

WOWTALE
Vuno Secures $6.8M Strategic Investment from Smilegate Investment to Drive Global Growth
Vuno, a medical AI company, secured a $6.8 million strategic investment from Smilegate Investment to strengthen long-term business stability and global expansion capabilities. The company is currently awaiting FDA 510k clearance and NTAP application review for VUNO Medu00ae-DeepCARSu00ae in the United States.
2025-12
AI Reporter America
VUNO's AI-Powered Cardiac Risk System Secures CE MDR and UKCA Certification for Global Expansion
VUNO Medu00ae-DeepCARSu00ae, an AI-powered cardiac arrest risk management system, received CE MDR certification in the EU and UKCA mark in the UK, accelerating its global market entry. This regulatory milestone positions the company for rapid expansion in Europe and the Middle East.
2025-05
VUNO (via PR Newswire)
Medical AI Company VUNO Reports Profit in Q3, Driven by DeepCARS Growth
VUNO Inc. announced profitability in Q3 2025, with consolidated revenue of KRW 10.8 billion, driven by the growth of its core product, VUNO Medu00ae-DeepCARSu00ae. The company achieved 11 consecutive quarters of revenue growth and is expanding globally.
2025-11
PR Newswire
VUNO Partners with European Firms to Advance DeepCARSu00ae Market Entry in Europe
VUNO signed a strategic MOU with Contextflow and Mesalvo to jointly advance VUNO Medu00ae-DeepCARSu00ae into the European market. This collaboration aims to support regulatory compliance, market access, and integration into electronic health record systems.
2025-10
KBR
VUNO's DeepCARS reduces cardiac arrests by 21% in secondary hospitals: study
A multicenter study published in 'Diagnostics' found that VUNO Med-DeepCARSu2122 reduced in-hospital cardiac arrests by 21% and in-hospital mortality by 15% in secondary-care hospitals without a Rapid Response System. The study highlights the clinical effectiveness of the AI-powered prediction device.
2026-06
KBR
VUNO breaks into Middle East market with ECG device deal
VUNO signed an exclusive distribution deal with Egypt's Health Arena to sell its portable electrocardiogram (ECG) device, HATIV P30, across five Middle Eastern countries. This marks VUNO's first export deal in the region, accelerating its overseas market expansion.
2026-07
KBR
VUNO to issue $18 mil. in bonds for US expansion, R&D
VUNO announced the issuance of $17.9 million in perpetual convertible bonds to fund its global business expansion, particularly in the U.S. market, focusing on clinical trials, regulatory approvals, and R&D for flagship products. The company has already received FDA approvals for VUNO Med-DeepBrain and VUNO Med-Chest X-ray Triage.
2024-12
PR Newswire
VUNO Secures FDA 510(k) Clearance for VUNO Medu00ae-DeepBrainu00ae
VUNO Inc. received 510(k) clearance from the FDA for its AI-powered brain quantification device, VUNO Medu00ae-DeepBrainu00ae. This device automates the identification, labeling, and quantification of brain structures from MRI images, providing valuable data for dementia and other neurodegenerative diseases.
2023-10

Frequently Asked Questions

VUNO offers AI-powered medical imaging diagnostic solutions across various modalities. For instance, VUNO Med®-Fundus AI™ assists in detecting various retinal diseases from fundus images, while VUNO Med®-Chest X-ray™ aids in identifying abnormalities in chest X-rays. They also have solutions for brain MRI analysis for neurodegenerative diseases and bone age assessment.
VUNO's biosignal analysis tools, such as the AI-powered cardiac arrest prediction solution VUNO Med®-DeepCARS™, are designed to provide real-time risk assessment to clinicians. Their medical speech recognition technology aims to streamline documentation and reduce administrative burden, allowing for more efficient data entry and improved physician-patient interaction.
VUNO focuses on leveraging AI to enable earlier and more accurate detection of diseases. For neurodegenerative diseases, their solutions analyze brain MRI to identify subtle changes indicative of conditions like Alzheimer's. In lung diseases, AI assists in flagging potential issues on chest X-rays, and for eye conditions, VUNO Med®-Fundus AI™ helps in the early identification of various ophthalmic pathologies.
VUNO is committed to obtaining necessary regulatory approvals for its medical AI devices. For example, VUNO Med®-DeepCARS™ has received FDA 510(k) clearance, and several of their products have obtained CE marking, indicating compliance with European health, safety, and environmental protection standards. They also hold Korean MFDS approval for various products.
VUNO's pricing models are typically tailored to the specific product and scale of implementation, often involving licensing agreements. They provide technical support to ensure seamless integration and operation of their AI solutions within healthcare systems. VUNO actively seeks partnerships with healthcare providers, research institutions, and technology companies to expand the reach and impact of their AI offerings.
VUNO has demonstrated significant growth and stability, evidenced by its successful IPO and continuous expansion of its product portfolio and market presence. The company is actively investing in R&D to further develop AI solutions for preventive healthcare and comprehensive health management, aiming to provide tools that support proactive health interventions and personalized care.

Related Companies

A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

Koios Care is a neurology-focused digital medicine company based in Antwerp, Belgium, specializing in AI-powered platforms. The company aims to revolutionize the management of neurological and chronic conditions, with an initial focus on Parkinson’s Disease. Koios Care’s platform utilizes everyday devices like smartphones and smartwatches to passively collect and analyze data, transforming it into objective, […]

Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]

Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.